#NuageTherapeutics
🔬 #NuageTherapeutics obtains €2.7M from @ageinves.bsky.social to develope NTX-A, a innovative therapy targeting the ASCL1-driven #LungCancer.
In partnership with 
@cniostopcancer.bsky.social, @embl.org and #VHIO.

➡️ https://linke.to/NuageTherapeuticsVHIO

@mmalumbres.bsky.social
December 3, 2025 at 11:03 AM
#PCBCommunity |🚀 #NuageTherapeutics strengthens its leadership in innovative therapies against #IDPs with the support of the #TorresQuevedo program from the @ageinves.bsky.social, accelerating the development of its innovative platform to design therapies targeting intrinsically disordered proteins.
Nuage Therapeutics strengthens its leadership in innovative therapies against IDPs thanks to the support of the Torres Quevedo program - Parc Científic de Barcelona
The company has successfully completed two projects funded through the Torres Quevedo Program (PTQ2021-011961 and PTQ2021-011994).
www.pcb.ub.edu
October 30, 2025 at 1:37 PM
#PCBCommunity | 📢 #NuageTherapeutics incorpora al seu equip directiu a Olivier Corminboeuf com a Head of #DrugDiscovery i Blandine Guimet com a Head of #People per a liderar i accelerar el desenvolupament de noves teràpies dirigides a proteïnes intrínsecament desordenades #IDPs. 🧬🚀

👉 tuit.cat/wX0Zt
July 31, 2025 at 11:46 AM
🚀 @nature.com is shining a spotlight on three #Barcelona homegrown spin-offs: #NuageTherapeutics, #OnaTherapeutics (both spin-offs from #IRBBarcelona and #ICREA) & SpliceBio.

Read more here ➡️ shorturl.at/TGrks

#IRBInnovation #Innovation #Biotech
#LifeSciences
April 25, 2025 at 9:04 AM
#PCBCommunity |🌍 #Barcelona brilla al mapa #biotech! 🚀Les startups #NuageTherapeutics, #OnaTherapeutics i #SpliceBio, amb seu al PCB, han estat destacades per @natureportfolio.nature.com com a referents d’una nova generació d’empreses que lideren l’auge del sector a la ciutat.

➕ info👉 qrcd.org/8Xbg
April 17, 2025 at 9:03 AM
#PCBCommunity |📢 La biotecnològica #NuageTherapeutics, centrada en el desenvolupament de #fàrmacs moduladors de proteïnes intrínsecament desordenades, anuncia canvis al seu #equip directiu: el Dr. Stuart Hughes s'incorpora com a #CEO i Vanessa Malier com a #presidenta del consell d'administració. 🚀👇
Nuage Therapeutics incorpora al Dr. Stuart Hughes com a CEO i a Vanessa Malier com a presidenta del consell d'administració - Parc Científic de Barcelona
La companyia anuncia el nomenament del Dr. Stuart Hughes com a nou director executiu, qui succeeix la fundadora Judit Anido, fins ara CEO.
www.pcb.ub.edu
April 1, 2025 at 2:19 PM